WNT5A and Ewing sarcoma: To test this hypothesis, we treated Ewing sarcoma cell lines with WNT974 to inhibit production of all endogenous Wnt ligands and then added exogenous recombinant Wnt5a to determine if the transcriptional changes are a direct result of Wnt5a in the microenvironment.